BIODESIX INC (BDSX) — insider trading
Health Care · NASDAQ
BIODESIX INC (BDSX) has 44 reported SEC Form 4 insider transactions in our data, including 3 open-market purchases and 10 open-market sales among the most recent 44 (latest 2026-09-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | PATIENCE JOHN | Director, Other | Option exercise / conversion (derivative) | 1,360 | — | $0 | Form 4 |
| 2026-09-30 | PATIENCE JOHN | Director, Other | Option exercise / conversion | 1,360 | — | — | Form 4 |
| 2026-08-12 | SCHULER JACK W | 10% owner, Other | Open-market purchase | 15,000 | $24.47 | $367.0K | Form 4 |
| 2026-08-11 | SCHULER JACK W | 10% owner, Other | Open-market purchase | 13,700 | $24.01 | $328.9K | Form 4 |
| 2026-08-10 | SCHULER JACK W | 10% owner, Other | Open-market purchase | 13,900 | $24.25 | $337.0K | Form 4 |
| 2026-06-30 | PATIENCE JOHN | Director, Other | Option exercise / conversion (derivative) | 1,361 | — | $0 | Form 4 |
| 2026-06-30 | PATIENCE JOHN | Director, Other | Option exercise / conversion | 1,361 | — | — | Form 4 |
| 2026-03-31 | PATIENCE JOHN | Director, Other | Option exercise / conversion (derivative) | 1,361 | — | $0 | Form 4 |
| 2026-03-31 | PATIENCE JOHN | Director, Other | Option exercise / conversion | 1,361 | — | — | Form 4 |
| 2026-02-23 | Hutton Scott | Director, Officer (President & CEO) | Open-market sale | 1,490 | $12.78 | $19.0K | Form 4 |
| 2026-02-23 | Vazquez Chris | Officer (Chief Accounting Officer) | Open-market sale | 211 | $12.78 | $2.7K | Form 4 |
| 2026-02-23 | Cowie Robin Harper | Officer (CFO, Sec'y & Treasurer) | Open-market sale | 535 | $12.78 | $6.8K | Form 4 |
| 2026-02-23 | O'Kane Kieran | Officer (Chief Commercial Officer) | Open-market sale | 535 | $12.78 | $6.8K | Form 4 |
| 2026-02-23 | Pestano Gary Anthony | Officer (Chief Development Officer) | Open-market sale | 556 | $12.78 | $7.1K | Form 4 |
| 2026-02-20 | Hutton Scott | Director, Officer (President & CEO) | Option exercise / conversion (derivative) | 4,844 | — | $0 | Form 4 |
| 2026-02-20 | Hutton Scott | Director, Officer (President & CEO) | Option exercise / conversion | 4,844 | — | — | Form 4 |
| 2026-02-20 | Vazquez Chris | Officer (Chief Accounting Officer) | Option exercise / conversion (derivative) | 563 | — | $0 | Form 4 |
| 2026-02-20 | Vazquez Chris | Officer (Chief Accounting Officer) | Option exercise / conversion | 563 | — | — | Form 4 |
| 2026-02-20 | Cowie Robin Harper | Officer (CFO, Sec'y & Treasurer) | Option exercise / conversion (derivative) | 1,469 | — | $0 | Form 4 |
| 2026-02-20 | Cowie Robin Harper | Officer (CFO, Sec'y & Treasurer) | Option exercise / conversion | 1,469 | — | — | Form 4 |
| 2026-02-20 | O'Kane Kieran | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 1,469 | — | $0 | Form 4 |
| 2026-02-20 | O'Kane Kieran | Officer (Chief Commercial Officer) | Option exercise / conversion | 1,469 | — | — | Form 4 |
| 2026-02-20 | Pestano Gary Anthony | Officer (Chief Development Officer) | Option exercise / conversion (derivative) | 1,528 | — | $0 | Form 4 |
| 2026-02-20 | Pestano Gary Anthony | Officer (Chief Development Officer) | Option exercise / conversion | 1,528 | — | — | Form 4 |
| 2026-02-10 | Pestano Gary Anthony | Officer (Chief Development Officer) | Open-market sale | 540 | $10.08 | $5.4K | Form 4 |
| 2026-02-10 | Cowie Robin Harper | Officer (CFO, Sec'y & Treasurer) | Open-market sale | 941 | $10.08 | $9.5K | Form 4 |
| 2026-02-10 | Hutton Scott | Director, Officer (President & CEO) | Open-market sale | 3,559 | $10.08 | $35.9K | Form 4 |
| 2026-02-10 | Vazquez Chris | Officer (Chief Accounting Officer) | Open-market sale | 101 | $10.08 | $1.0K | Form 4 |
| 2026-02-10 | O'Kane Kieran | Officer (Chief Commercial Officer) | Open-market sale | 584 | $10.08 | $5.9K | Form 4 |
| 2026-02-09 | Pestano Gary Anthony | Officer (Chief Development Officer) | Option exercise / conversion (derivative) | 1,413 | — | $0 | Form 4 |
| 2026-02-09 | Pestano Gary Anthony | Officer (Chief Development Officer) | Option exercise / conversion (derivative) | 68 | — | $0 | Form 4 |
| 2026-02-09 | Pestano Gary Anthony | Officer (Chief Development Officer) | Option exercise / conversion | 1,481 | — | — | Form 4 |
| 2026-02-09 | Cowie Robin Harper | Officer (CFO, Sec'y & Treasurer) | Option exercise / conversion (derivative) | 2,427 | — | $0 | Form 4 |
| 2026-02-09 | Cowie Robin Harper | Officer (CFO, Sec'y & Treasurer) | Option exercise / conversion (derivative) | 157 | — | $0 | Form 4 |
| 2026-02-09 | Cowie Robin Harper | Officer (CFO, Sec'y & Treasurer) | Option exercise / conversion | 2,584 | — | — | Form 4 |
| 2026-02-09 | Hutton Scott | Director, Officer (President & CEO) | Option exercise / conversion (derivative) | 9,388 | — | $0 | Form 4 |
| 2026-02-09 | Hutton Scott | Director, Officer (President & CEO) | Option exercise / conversion (derivative) | 610 | — | $0 | Form 4 |
| 2026-02-09 | Hutton Scott | Director, Officer (President & CEO) | Option exercise / conversion | 9,998 | — | — | Form 4 |
| 2026-02-09 | Vazquez Chris | Officer (Chief Accounting Officer) | Option exercise / conversion (derivative) | 235 | — | $0 | Form 4 |
| 2026-02-09 | Vazquez Chris | Officer (Chief Accounting Officer) | Option exercise / conversion (derivative) | 28 | — | $0 | Form 4 |
| 2026-02-09 | Vazquez Chris | Officer (Chief Accounting Officer) | Option exercise / conversion | 263 | — | — | Form 4 |
| 2026-02-09 | O'Kane Kieran | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 1,527 | — | $0 | Form 4 |
| 2026-02-09 | O'Kane Kieran | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 73 | — | $0 | Form 4 |
| 2026-02-09 | O'Kane Kieran | Officer (Chief Commercial Officer) | Option exercise / conversion | 1,600 | — | — | Form 4 |
Ask the chat about BDSX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: BIODESIX INC (BDSX).
Last updated 2026-09-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.